Content - Preview

Preview of papers in the copy-editing process

These articles have been accepted for publication in Acta Dermato-Venereologica and are currently being edited and typeset. Readers should note that articles published below have been fully refereed, but have not been through the copy-editing and proof correction process. Only Abstract is possible to read. When this process is finalized the complete paper will be able to find.
SHORT COMMUNICATION
Screening for Body Dysmorphic Disorder among Patients Seeking Dermatological and Cosmetic Care: A Cross-sectional Study
Valérie Peeters, Sherief R. Janmohamed, Samira Baharlou, Jan Gutermuth, Ria Willemsen
Abstract is missing (Short communication)
Abstract
CLINICAL REPORT
Interobserver Agreement on Dermoscopic Features and their Associations with In Situ and Invasive Cutaneous Melanomas
Sam Polesie, Lisa Sundback, Martin Gillstedt, Hannah Ceder, Johan Dahlén Gyllencreutz, Julia Fougelberg, Eva Johansson Backman, Jenna Pakka, Oscar Zaar, John Paoli
Several melanoma-specific dermoscopic features have been described, some of which have been reported as indicative of in situ or invasive melanomas. To assess the usefulness of these features to differentiate between these 2 categories, a retrospective, single-centre investigation was conducted. Dermoscopic images of melanomas were reviewed by 7 independent dermatologists. Fleiss’ kappa (κ) was ...
Abstract
SHORT COMMUNICATION
Multiple Keratoacanthoma Centrifugum Marginatum in a Patient with Primary Myelofibrosis: A Case Report with Dermoscopic Findings
Magdalena Żychowska, Joanna Muda-Urban, Kamila Jaworecka, Ewa Kaznowska, Adam Reich
Abstract is missing (Short communication)
Abstract
CLINICAL REPORT
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study
Riccardo G. Borroni, Piergiorgio Malagoli, Luigi Gargiulo, Mario Valenti, Giulia Pavia, Paola Facheris, Emanuela Morenghi, Isotta Giunipero di Corteranzo, Alessandra Narcisi, Michela Ortoncelli, Paolo Dapavo, Antonio Costanzo
Risankizumab is a humanized monoclonal antibody that binds the p19 subunit of interleukin-23. It is approved for treatment of moderate-severe chronic plaque psoriasis. This retrospective study included 66 consecutive adults with moderate-to-severe psoriasis vulgaris treated with risankizumab in monotherapy up to week 40 in a “real-life” setting. At week 40, 98.7%, 85.7% and 62.3% of patients a ...
Abstract
SHORT COMMUNICATION
Xerosis in Patients with Type 2 Diabetes: An Italian Multicentre Study
Luca Stingeni, Marta Tramontana, Lorenzo Cordera, Michela Castello, Aurora Parodi
Abstract is missing (Short communication)
Abstract
SHORT COMMUNICATION
A Rare, Recurrent Spindle Cell Lipoma of the Nose
Minna E. Kubin, Ulla Lantto, Outi Lindgren, Kaisa Tasanen
Abstract is missing (Short communication)
Abstract
SHORT COMMUNICATION
A Comment on: “Patient and Tumour Characteristics of Keratoacanthoma in a Large, Community-based Cohort Study from Queensland, Australia”
Daniel Mazzoni, Jim Muir
Abstract is missing (Short communication)
Abstract
INVESTIGATIVE REPORT
Detailed Long-term Dynamics of Neutrophil-to-Lymphocyte Ratio under Biologic Treatment Reveals Differential Effects of Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists
Jochen H.O. Hoffmann, Christian Knoop, Alexander Enk, Eva N. Hadaschik
Psoriasis is thought to be associated with a reduced life expectancy through systemic inflammation. A comparative, retrospective analysis of neutrophil-to-lympho-cyte ratio, a biomarker of systemic inflammation and cardiovascular risk, under 196 treatments with tumour necrosis factor-α and interleukin-12/23 antagonists was performed. Neutrophil-to-lympho-cyte ratio decreased significantly within ...
Abstract
INVESTIGATIVE REPORT
Biogeographical Landscape of the Human Face Skin Microbiome Viewed in High Definition
Michael Brandwein, Garold Fuks, Avigail Israel, Emmilia Hodak, Fareed Sabbah, Doron Steinberg, Zvi Bentwich, Noam Shental, Shiri Meshner
The bacterial population that colonizes the human face imparts physiochemical and physiological effects on the facial skin. These skin-microbe interactions impact dermatological, cosmetic and skincare applications due to the centrality of the human face in daily interactions. However, fine-scale characterization of the human face skin microbiome is lacking. Using 16S rRNA sequencing and 3D cartogr ...
Abstract
CLINICAL REPORT
Long-term Outcome of Chilblains Associated with SARS-CoV-2
Florence Poizeau, Sébastien Barbarot, Yannick Le Corre, Emilie Brenaut, Mahtab Samimi, Hélène Aubert, Alexis Toubel, Alain Dupuy
Numerous cases of chilblains have been observed associated with the COVID-19 pandemic. The aims of this study were to provide comprehensive follow-up data for patients reporting chilblains, and to determine the risk factors for incomplete recovery. Patients referred to 5 hospitals in France between March and May 2020 for chilblains were surveyed on December 2020. A teleconsultation was offered. Am ...
Abstract
INVESTIGATIVE REPORT
Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis
Silvia Mariel Ferrucci, Simona Tavecchio, Luisa Angileri, Teresa Surace, Emilio Berti, Massimiliano Buoli
The aim of this study was to detect demographic and clinical factors associated with affective symptoms and quality of life in patients with severe atopic dermatitis. First, one-way analyses of variance and correlations were performed to compare a large set of qualitative and quantitative clinical variables. Three final multivariable regression models were performed, with depression/anxiety subsca ...
Abstract
INVESTIGATIVE REPORT
Antipruritic Effect of Topical Acetaminophen Gel in Histaminergic and Non-histaminergic Itch Provocation: A Double-blind, Vehicle-controlled Pilot Study
Leigh A. Nattkemper, Kaining Zhi, Kaeli E. Romero, Serena M. Shah, Terresa Ju, Kayla Fourzali, Rachel Shireen Golpanian, Flor MacQuhae, Yiong Huak Chan, David B. Lebo, Gil Yosipovitch
There is a need for new topical antipruritics that are effective on many types of itch. This study examined the antipruritic efficacy of a new formulation of topical acetaminophen. In vitro skin permeability studies showed that 2.5% and 5% formulations are able to rapidly deliver an adequate amount of the drug into the skin. In a double-blind, vehicle-controlled, randomized study in 17 healthy vol ...
Abstract
CLINICAL REPORT
General Burden of Adult Atopic Dermatitis: An Observational Study of Disease Perceptions among Patients and Dermatologists in France
Angèle Soria, Claire Thénié, Christina Bienenfeld, Delphine Staumont-Sallé
It is important to understand patients’ and dermatologists’ perceptions of various aspects of atopic dermatitis, but there is a lack of studies on quality of life and stakeholder viewpoints in this therapy area. The aim of this study was to compare patients’ and dermatologists’ viewpoints regarding the impact of atopic dermatitis that is uncontrolled by topical corticosteroids. Data were c ...
Abstract
SHORT COMMUNICATION
Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report
Karim Souaid, Bénédicte Oulès, Pierre Sohier, Lydia Deschamps, Sélim Aractingi, Nicolas Dupin
Abstract is missing (Short communication)